AMAG Pharmaceuticals, Inc. (AMAG) financial statements (2020 and earlier)

Company profile

Business Address 1100 WINTER STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments172394329579466144214
Cash and cash equivalents11325319227422911927
Short-term investments5914113730523825187
Receivables94851049286387
Inventory, net of allowances, customer advances and progress billings32273737414117
Inventory32273737414117
Other undisclosed current assets1919121014517
Total current assets:317525482719607274244
Noncurrent Assets
Inventory, Noncurrent     8 
Operating lease, right-of-use asset23
Property, plant and equipment4826242922
Intangible assets, net (including goodwill)4466401,3441,7321,83653917
Goodwill423423639639639206 
Intangible assets, net (excluding goodwill)242177041,0921,19733417
Restricted cash and investments0013320
Deferred income tax assets1
Other noncurrent assets 11113172
Other undisclosed noncurrent assets 1   546 
Total noncurrent assets:4756501,3711,7601,8811,11521
TOTAL ASSETS:7911,1751,8532,4782,4871,389265
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2041441861601119830
Accounts payable2714104573
Accrued liabilities1771301751561068122
Employee-related liabilities     105
Debt421 211834 
Restructuring reserve     2
Business combination, contingent consideration, liability0049  1
Deferred revenue and credits423520448
Other undisclosed current liabilities   9797(13)(5)
Total current liabilities:20816527831324616633
Noncurrent Liabilities
Long-term debt and lease obligation297262735965986167 
Long-term debt, excluding current maturities277262735965986167 
Operating lease, liability20
Liabilities, other than long-term debt015121519830146
Deferred revenue and credits24155646
Deferred tax liabilities, net 2419718978 
Other liabilities01234  
Business combination, contingent consideration, liability 01  218
Other undisclosed noncurrent liabilities   5112629414
Total noncurrent liabilities:2972637851,2311,30976260
Total liabilities:5054291,0631,5441,55592993
Stockholders' equity
Stockholders' equity attributable to parent286747790934932460172
Common stock0000000
Additional paid in capital1,2981,2931,2721,2381,234794642
Accumulated other comprehensive loss(3)(4)(4)(4)(4)(4)(3)
Accumulated deficit(1,009)(542)(478)(300)(298)(330)(466)
Total stockholders' equity:286747790934932460172
TOTAL LIABILITIES AND EQUITY:7911,1751,8532,4782,4871,389265

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues32847461053241812481
Revenue, net61053241812481
Cost of revenue
(Cost of Goods and Services Sold)
(107)(216)(183)(117)(89)(22)(14)
Gross profit:22125842741533010266
Operating expenses(666)(305)(720)(336)(219)(113)(80)
Other undisclosed operating income     7 
Operating income (loss):(446)(47)(293)79111(4)(13)
Nonoperating income (expense)(21)(83)(77)3(8)(14)2
Investment income, nonoperating4533211
Other nonoperating income (expense)0(0)(0)0(9)  
Interest and debt expense(26)(36)(11)(73)(64)(15) 
Other undisclosed income from continuing operations before equity method investments, income taxes     152
Income (loss) from continuing operations before equity method investments, income taxes:(492)(166)(381)940(17)(10)
Other undisclosed income from continuing operations before income taxes263611    
Income (loss) from continuing operations before income taxes:(467)(130)(370)940(17)(10)
Income tax expense (benefit)0(40)171(12)(7)153 
Income (loss) from continuing operations:(466)(169)(199)(2)33136(10)
Income from discontinued operations 17     
Net income (loss):(466)(153)(199)(2)33136(10)
Other undisclosed net income attributable to parent 87     
Net income (loss) available to common stockholders, diluted:(466)(66)(199)(2)33136(10)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(466)(153)(199)(2)33136(10)
Comprehensive income (loss):(466)(153)(199)(2)33136(10)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent187(0)0(1)(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(466)(66)(199)(2)32136(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: